CYTK
Cytokinetics Inc
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report1 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
−5.67%
vs ±7.7% implied · ×0.73
shaded = implied · ▲▼ = realized
No thesis.
Fund move
Fund move
Cytokinetics Inc
62.06
−0.93 · −1.48%
post 62.06 +0.01%
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | BlackRockBlackRockindex-like | $1.7B | 11.97% | +21.43% | |
| 2 | T. Rowe Price Investment ManagementT. Rowe Price | $1.6B | 11.15% | +6.82% | |
| 3 | Wellington Management GroupWellington | $590.5M | 4.13% | −13.46% | |
| 4 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $571.8M | 4.00% | +14.85% | |
| 5 | State StreetState Streetindex-like | $553.2M | 3.87% | +13.04% | |
| 6 | Vanguard Capital ManagementVanguardindex-like | $521.2M | 3.64% | +11.46% | |
| 7 | FMRFMR | $428.7M | 3.00% | −53.08% | |
| 8 | venBio Select AdvisorvenBio Select Advisor | $425.9M | 2.98% | +50.00% | |
| 9 | Bank of AmericaBank of America | $394.9M | 2.76% | +48.32% | |
| 10 | Susquehanna International GroupSusquehanna International | $317.7M | 2.22% | +67.79% | |
| 11 | Geode Capital ManagementGeodeindex-like | $316.3M | 2.21% | +15.46% | |
| 12 | RTW InvestmentsRTW | $243.8M | 1.71% | +5.18% | |
| 13 | Armistice CapitalArmistice Capital | $232.7M | 1.63% | +2.51% | |
| 14 | Polar Capital HoldingsPolar Capital | $192.0M | 1.34% | +35.66% | |
| 15 | Citadel AdvisorsCitadel | $167.5M | 1.17% | +26.53% | |
| 16 | T. Rowe Price AssociatesT. Rowe Price | $166.9M | 1.17% | +23.65% | |
| 17 | Goldman Sachs GroupGoldman Sachs | $152.9M | 1.07% | −26.92% | |
| 18 | Capital Research Global InvestorsCapital Research Global Investors | $143.7M | 1.00% | +118.76% | |
| 19 | Northern TrustNorthern Trustindex-like | $140.3M | 0.98% | +14.27% | |
| 20 | JPMorgan ChaseJPMorgan Chase | $139.2M | 0.97% | +75.80% | |
| 21 | William Blair Investment ManagementWilliam Blair | $136.6M | 0.96% | +47.43% | |
| 22 | Integral Health Asset ManagementIntegral Health | $136.3M | 0.95% | −38.46% | |
| 23 | Point72 Asset ManagementPoint72 | $135.3M | 0.95% | +140.29% | |
| 24 | Charles Schwab Investment ManagementCharles Schwabindex-like | $133.4M | 0.93% | +12.08% | |
| 25 | Morgan StanleyMorgan Stanley | $128.7M | 0.90% | +0.35% |
487 managers report $14.3B of Cytokinetics on form 13F for the quarter ended Jun 30 '26. 46 of them hold 80% of it; BlackRock is largest at 11.97%.
Linked news
Expected move
Inputs8Q avg ±4.1%·×1.61·rich
straddle ±9.1%
spot 62.03exp Nov 20ATM strike 62.5ATM straddle 6.62IV 60%